pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 443
- Patents
- 706
Bavencio 20 mg/mL concentrate for solution for infusion
Approved · small molecule · urothelial cancer, Bladder cancer, muscle invasive bladder cancer
Bavencio 20 mg/mL concentrate for solution for infusion for urothelial cancer, Bladder cancer, muscle invasive bladder cancer is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Internal code NL75848.056.20
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Disc Medicine
- Phase
- Approved
- Modality
- small_molecule
- Indication
- urothelial cancer, Bladder cancer, muscle invasive bladder cancer
- Status
- active
- Trials
- 1